An Overview on Potential Neuroprotective Compounds for Management of Alzheimer's Disease

E-ISSN： 1996-3181|11|8|1006-1011

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.11, Iss.8, 2012-12, pp. : 1006-1011

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Humanin: a potential peptide for neuroprotective therapy against Alzheimer's disease

By Niikura Takako

Expert Opinion on Drug Discovery, Vol. 2, Iss. 9, 2007-09 ,pp. : 1273-1282

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotective Therapies for Alzheimer's Disease

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 705-717

Bentham Science Publishers

Access to resources Recommend Favorite

The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer’s Disease

Current Pharmaceutical Design, Vol. 21, Iss. 39, 2015-12 ,pp. : 5725-5735

Bentham Science Publishers

Access to resources Recommend Favorite

Resveratrol, A Neuroprotective Supplement for Alzheimer's Disease

Current Pharmaceutical Design, Vol. 18, Iss. 1, 2012-01 ,pp. : 27-33

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's Disease-Associated Neurotoxic Mechanisms and Neuroprotective Strategies

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 4, 2005-08 ,pp. : 383-403

Bentham Science Publishers

Access to resources Recommend Favorite